Abstract 7862: Population analysis and immunologic landscape of melanoma in people living with HIV.

Abstract Purpose: To dissect the clinical and immunological features of people living with HIV (PLWH) diagnosed with melanoma, who have consistently shown worse outcomes than HIV-negative individuals (PLw/oH) with the same cancer. Experimental Design: We analyzed electronic health records from 1,087 PLWH and 394,437 PLw/oH with melanoma. Demographic and clinical characteristics were compared. Spatial immune transcriptomics (72 immune-related genes) was performed on melanoma tumor samples (n=11), with downstream validation using multiplex immunofluorescence (n=15 PLWH, n=14 PLw/oH). Results: PLWH were diagnosed at a younger age, had greater representation of Hispanic and Black individuals, and showed reduced survival. They also had a markedly increased risk of brain metastases. PLWH experienced significant delays in initiating immune checkpoint inhibitor (ICI) therapy and had worse post-ICI survival, even after balancing covariates. Spatial transcriptomics revealed a more immunosuppressive tumor microenvironment in PLWH, with increased transcription of immune checkpoints (PD1, LAG3) and reduced antigen-presentation markers (HLA-DRB, B2M), with distinct spatial distributions in tumors and surrounding microenvironments. Multiplex immunofluorescence demonstrated features of an exhausted CD8+ T cell compartment, including enrichment of PD1intLAG3- and PD1intLAG3+ subpopulations, and a significant accumulation of myeloid-derived suppressor cells (CD11b+ HLA-DR- CD33+). Conclusions: Melanoma in PLWH is associated with distinct clinical and immunological features, including delayed ICI treatment, reduced survival, and an immunosuppressive microenvironment with exhausted CD8+ T cells and expanded myeloid-derived suppressor cells. These findings suggest that chronic HIV infection may impair antitumor immunity in melanoma. Targeting the pathways identified here may improve therapeutic responses and outcomes in this population. Citation Format: Lindsay Barger, Derek Wang, Ashley Saravia, Valeria Mezzano-Robinson, Gyles Ward, Cynthia Loomis, Carly Feldman, Madalina Tuluc, Rino S. Seedor, Peter J. Gaskill, Anna E. Coghill, Gita Suneja, Iman Dehzangi, Jenna Hope, George Jour, Gabriele Romano. Population analysis and immunologic landscape of melanoma in people living with HIV [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7862.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-7862
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 7862: Population analysis and immunologic landscape of melanoma in people living with HIV.

Peter J. Gaskill, Gabriele Romano, Cynthia A. Loomis, Rino S. Seedor et al.
Cancer Research
Cancer Immunotherapy and Biomarkers
article

Abstract 7862: Population analysis and immunologic landscape of melanoma in people living with HIV.

Peter J. Gaskill, Gabriele Romano, Cynthia A. Loomis, Rino S. Seedor, Lindsay N. Barger, Valeria Mezzano, Madalina Tuluc, George Jour, Gyles Ward, Jenna Hope, Derek Wang, Iman Dehzangi, Ashley Saravia, Carly Feldman, Anna E. Coghill, Gita Suneja
article en

Abstract

Abstract Purpose: To dissect the clinical and immunological features of people living with HIV (PLWH) diagnosed with melanoma, who have consistently shown worse outcomes than HIV-negative individuals (PLw/oH) with the same cancer. Experimental Design: We analyzed electronic health records from 1,087 PLWH and 394,437 PLw/oH with melanoma. Demographic and clinical characteristics were compared. Spatial immune transcriptomics (72 immune-related genes) was performed on melanoma tumor samples (n=11), with downstream validation using multiplex immunofluorescence (n=15 PLWH, n=14 PLw/oH). Results: PLWH were diagnosed at a younger age, had greater representation of Hispanic and Black individuals, and showed reduced survival. They also had a markedly increased risk of brain metastases. PLWH experienced significant delays in initiating immune checkpoint inhibitor (ICI) therapy and had worse post-ICI survival, even after balancing covariates. Spatial transcriptomics revealed a more immunosuppressive tumor microenvironment in PLWH, with increased transcription of immune checkpoints (PD1, LAG3) and reduced antigen-presentation markers (HLA-DRB, B2M), with distinct spatial distributions in tumors and surrounding microenvironments. Multiplex immunofluorescence demonstrated features of an exhausted CD8+ T cell compartment, including enrichment of PD1intLAG3- and PD1intLAG3+ subpopulations, and a significant accumulation of myeloid-derived suppressor cells (CD11b+ HLA-DR- CD33+). Conclusions: Melanoma in PLWH is associated with distinct clinical and immunological features, including delayed ICI treatment, reduced survival, and an immunosuppressive microenvironment with exhausted CD8+ T cells and expanded myeloid-derived suppressor cells. These findings suggest that chronic HIV infection may impair antitumor immunity in melanoma. Targeting the pathways identified here may improve therapeutic responses and outcomes in this population. Citation Format: Lindsay Barger, Derek Wang, Ashley Saravia, Valeria Mezzano-Robinson, Gyles Ward, Cynthia Loomis, Carly Feldman, Madalina Tuluc, Rino S. Seedor, Peter J. Gaskill, Anna E. Coghill, Gita Suneja, Iman Dehzangi, Jenna Hope, George Jour, Gabriele Romano. Population analysis and immunologic landscape of melanoma in people living with HIV [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7862.

Cancer ResearchVol. 86(7_Supplement)
Rutgers, The State University of New Jersey (US), Thomas Jefferson University (US), Huntsman Cancer Institute (US), Moffitt Cancer Center (US), NYU Langone Health (US), Drexel University (US)
Good health and well-being
Openalex Percentile: Top 34%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.